The global AI in Radiology market size was valued at USD 751.8 million in 2025 and is projected to reach USD 7826.5 million by 2035, expanding at a CAGR of 26.4% from 2026 to 2035. Market growth is supported by the increasing volume of diagnostic imaging procedures, growing radiologist shortages, rising adoption of AI-powered image analysis and workflow automation solutions, and expanding integration of artificial intelligence into precision diagnostics and clinical decision-making processes.
|
Years |
2022 |
2023 |
2024 |
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
Revenue (USD Mn) |
372.2 |
XX |
XX |
751.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
7826.5 |
|
Region |
2022 |
2023 |
2024 |
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
North America |
XX |
XX |
XX |
390.9 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
3414.4 |
|
Europe |
XX |
XX |
XX |
173.6 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
1579 |
|
Asia Pacific |
XX |
XX |
XX |
137.5 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
1675.7 |
|
Latin America |
XX |
XX |
XX |
21.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
221.6 |
|
Middle East & Africa |
XX |
XX |
XX |
27.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
267.4 |
|
|
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
Conservative |
1134.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
10153.4 |
|
Likely |
751.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
7826.5 |
|
Optimistic |
1134.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
15886.5 |
The growing volume of diagnostic imaging procedures worldwide is a major factor driving the adoption of AI in radiology. The increasing prevalence of cancer, cardiovascular diseases, neurological disorders, and respiratory conditions has significantly expanded the demand for CT, MRI, X-ray, PET, and ultrasound examinations. According to the OECD, the utilization of advanced imaging technologies has increased substantially over the past two decades, with CT scan volumes rising by more than 60% and MRI examinations increasing by over 80% across OECD countries between 2000 and 2016. This sustained growth has placed considerable pressure on radiology departments to process larger numbers of imaging studies while maintaining diagnostic accuracy.
Additionally, OECD healthcare statistics indicate continued growth in the availability and use of CT, MRI, and PET imaging systems across developed healthcare markets, reflecting the expanding role of medical imaging in disease diagnosis and treatment planning. The aging global population further amplifies imaging demand, as older adults require more frequent diagnostic assessments. OECD data show that more than 252 million people aged 65 years and above lived across OECD countries in 2023, including over 67 million individuals aged 80 years and older. This demographic shift is expected to generate a sustained increase in imaging workloads, encouraging healthcare providers to deploy AI-powered image analysis, prioritization, and workflow optimization solutions. AI enables faster image interpretation, improves productivity, and supports radiologists in managing escalating imaging volumes without compromising clinical quality.
The increasing shortage of radiologists worldwide is significantly accelerating the adoption of artificial intelligence in radiology. As imaging volumes continue to grow due to the rising prevalence of chronic diseases and aging populations, healthcare systems are facing mounting challenges in maintaining timely diagnostic services. AI-powered radiology solutions are increasingly being deployed to support image interpretation, automate routine tasks, prioritize urgent cases, and improve reporting efficiency.
According to research published in Nature npj Imaging, the United States has approximately 34,000 practicing radiologists, while 32% of the workforce is over the age of 55, highlighting the potential impact of upcoming retirements on diagnostic capacity. The study further reported that the American College of Radiology (ACR) job board listed 1,930 open radiology positions, whereas fewer than 1,400 radiology residents match annually, demonstrating a widening gap between workforce demand and supply. These shortages are contributing to increased reporting workloads and longer turnaround times across healthcare facilities.
As hospitals and diagnostic imaging centers seek to address workforce constraints without compromising diagnostic accuracy, AI is emerging as a critical technology for enhancing radiologist productivity and operational efficiency. Advanced AI algorithms can assist in lesion detection, image triage, workflow prioritization, and report generation, enabling healthcare providers to manage increasing imaging volumes more effectively. Consequently, the persistent shortage of radiology professionals continues to serve as a major growth catalyst for the AI in Radiology Market.
The increasing reliance on large-scale medical imaging datasets for artificial intelligence development has heightened concerns regarding patient privacy, cybersecurity, and data protection. AI-powered radiology platforms require access to substantial volumes of imaging data, electronic health records, and clinical information to train and validate algorithms. However, the growing frequency of healthcare cyberattacks, and data breaches is creating hesitation among healthcare providers regarding AI implementation, particularly when cloud-based infrastructure and third-party data-sharing arrangements are involved.
According to healthcare cybersecurity data, 275 million healthcare records were breached in 2024, representing the largest annual exposure ever recorded within the healthcare sector. Additionally, ransomware attacks targeting healthcare organizations increased by 32%, while the Change Healthcare cyberattack alone exposed information associated with approximately 190 million individuals. Separately, cybersecurity researchers identified more than 1.2 million internet-connected healthcare devices globally that were improperly secured, exposing sensitive medical information including MRI scans, X-rays, and patient records. These incidents have increased regulatory scrutiny and forced healthcare organizations to invest heavily in cybersecurity measures before deploying AI-enabled solutions.
As radiology departments increasingly utilize AI-driven image analysis, cloud-based diagnostics, and interconnected healthcare systems, concerns surrounding unauthorized access, data leakage, and regulatory non-compliance continue to challenge adoption. Healthcare providers must balance the benefits of AI innovation with stringent privacy requirements, making cybersecurity and data governance significant barriers to widespread implementation.
The commercialization of AI-powered radiology solutions remains constrained by extensive regulatory review processes and clinical validation requirements. Healthcare providers and regulators demand robust evidence demonstrating safety, accuracy, reliability, and generalizability across diverse patient populations before AI systems can be widely adopted in clinical practice. Obtaining such evidence requires significant investments in clinical trials, dataset validation, post-market monitoring, and regulatory documentation, increasing both development costs and time-to-market.
According to a peer-reviewed study published in the National Library of Medicine, the U.S. FDA had authorized 950 AI/ML-enabled medical devices, of which 723 devices (76%) were related to radiology applications. However, the study also highlights the rigorous regulatory environment surrounding AI-enabled devices and the substantial documentation required for authorization. Another analysis reported that among 168 machine learning-enabled devices approved in 2024, 94.6% were cleared through the FDA's 510(k) pathway, demonstrating the extensive review and compliance procedures manufacturers must navigate before commercialization. Additionally, studies examining FDA-authorized AI technologies indicate that 84.4% of AI-enabled devices rely on imaging data, further emphasizing the need for continuous clinical validation and performance monitoring in radiology applications.
These stringent approval requirements can delay product launches, increase development costs, and create barriers for smaller innovators. Consequently, regulatory complexity and the need for extensive clinical validation remain significant restraints on the growth of the AI in Radiology Market.
The growing adoption of artificial intelligence in population-scale cancer screening programs presents a significant opportunity for the AI in Radiology Market. Healthcare systems worldwide are increasingly exploring AI-assisted screening solutions to improve early disease detection, reduce radiologist workloads, and enhance diagnostic accuracy. Breast cancer screening, lung cancer detection, and other preventive imaging programs are emerging as key areas where AI can deliver measurable clinical and operational benefits.
According to a study published in Nature Digital Medicine, 84.4% of FDA-authorized AI-enabled medical devices utilize imaging data as their primary input, highlighting the dominant role of imaging-based AI technologies in healthcare. Furthermore, a JAMA Network Open analysis reported that 692 FDA-approved AI-enabled medical devices (76.6%) are focused on radiology, reflecting strong industry innovation and regulatory acceptance within imaging applications. As governments and healthcare organizations expand cancer screening initiatives, these technologies are increasingly being incorporated into routine clinical workflows.
Recent clinical evidence further demonstrates the value of AI-assisted screening. A large-scale Swedish mammography study involving more than 100,000 women found that AI-supported breast cancer screening reduced subsequent cancer diagnoses by 12%, while improving early cancer detection rates. Such findings are encouraging healthcare providers to evaluate AI as a tool for addressing growing screening volumes and workforce shortages. As national screening programs continue to expand globally, the integration of AI-powered image analysis, risk stratification, and automated triage systems is expected to create substantial growth opportunities for radiology AI vendors.
|
By Component |
2025 |
|
AI-enabled Devices |
24.6% |
|
Software & Platform |
62.8% |
|
Services |
12.6% |
Software & Platform accounted for the largest share of the AI in Radiology Market due to its widespread adoption in image analysis, workflow automation, clinical decision support, and reporting applications. Healthcare providers increasingly deploy AI software solutions to improve diagnostic accuracy, reduce interpretation time, and optimize radiology operations without requiring substantial investments in new imaging hardware.
Services is projected to register the fastest growth during the forecast period, driven by increasing demand for AI implementation, integration, training, maintenance, and consulting services. As healthcare organizations expand AI deployments across radiology departments, the need for technical support, workflow customization, regulatory compliance assistance, and continuous algorithm optimization is accelerating service adoption globally.
Computer Vision Techniques held the largest share of the AI in Radiology Market owing to their critical role in medical image interpretation, lesion detection, image segmentation, and pattern recognition across CT, MRI, X-ray, mammography, and ultrasound modalities. The technology enables automated analysis of complex imaging datasets, helping radiologists improve diagnostic accuracy, efficiency, and consistency in clinical decision-making.
Natural Language Processing (NLP) is expected to witness the fastest growth during the forecast period due to its increasing use in radiology reporting, clinical documentation, and information extraction from unstructured healthcare data. NLP solutions help automate report generation, improve workflow efficiency, facilitate clinical decision support, and enhance interoperability between radiology systems and electronic health records.
Computed Tomography (CT) accounted for the largest share of the AI in Radiology Market due to its extensive use in diagnosing cancer, cardiovascular diseases, neurological disorders, trauma, and pulmonary conditions. The large volume of CT examinations generated globally creates significant opportunities for AI-powered image analysis, lesion detection, workflow optimization, and automated diagnostic support applications.
Mammography / Tomosynthesis is projected to be the fastest-growing segment during the forecast period, driven by expanding breast cancer screening programs and increasing adoption of AI-assisted detection technologies. AI solutions are improving early cancer identification, reducing false positives, enhancing radiologist productivity, and supporting population-scale screening initiatives, thereby accelerating adoption across healthcare systems worldwide.
Image Analysis held the largest share of the AI in Radiology Market owing to its widespread application in detecting abnormalities, identifying disease patterns, segmenting anatomical structures, and supporting diagnostic interpretation across multiple imaging modalities. The growing demand for improved diagnostic accuracy and faster image assessment continues to drive the adoption of AI-powered image analysis solutions in radiology departments.
Workflow Optimization is expected to register the fastest growth during the forecast period due to increasing pressure on healthcare providers to improve operational efficiency and manage rising imaging volumes. AI-powered workflow tools assist with case prioritization, automated reporting, scheduling, and workload balancing, helping radiology departments reduce turnaround times and address workforce shortages effectively.
Hospitals accounted for the largest share of the AI in Radiology Market due to their high volume of diagnostic imaging procedures, advanced healthcare infrastructure, and substantial investments in digital health technologies. The adoption of AI solutions for image interpretation, workflow automation, and clinical decision support is particularly strong in hospital-based radiology departments seeking to enhance diagnostic accuracy and operational efficiency.
Diagnostic Imaging Centers are projected to witness the fastest growth during the forecast period, driven by increasing imaging workloads, demand for rapid diagnostic services, and the need to optimize radiologist productivity. AI technologies enable these facilities to streamline image analysis, reduce reporting turnaround times, improve patient throughput, and deliver cost-effective diagnostic services across diverse imaging modalities.
|
By Geography |
2022 |
2025 |
2035 |
|
North America |
XX |
390.9 |
XX |
|
US |
XX |
362 |
XX |
|
Canada |
XX |
28.9 |
XX |
|
Europe |
XX |
173.6 |
XX |
|
Germany |
XX |
35.6 |
XX |
|
UK |
XX |
22.2 |
XX |
|
France |
XX |
27 |
XX |
|
Italy |
XX |
14.9 |
XX |
|
Spain |
XX |
14.2 |
XX |
|
Switzerland |
XX |
5.3 |
XX |
|
Netherlands |
XX |
3.6 |
XX |
|
Rest of Europe |
XX |
50.5 |
XX |
|
Asia Pacific |
XX |
137.5 |
XX |
|
China |
XX |
57.6 |
XX |
|
India |
XX |
10.4 |
XX |
|
Japan |
XX |
21.7 |
XX |
|
South Korea |
XX |
19.6 |
XX |
|
Singapore |
XX |
4.9 |
XX |
|
Australia |
XX |
7.1 |
XX |
|
Thailand |
XX |
1.7 |
XX |
|
Malaysia |
XX |
3.4 |
XX |
|
Philippines |
XX |
2.7 |
XX |
|
Indonesia |
XX |
2.2 |
XX |
|
Rest of Asia Pacific |
XX |
5.7 |
XX |
|
Middle East & Africa |
XX |
27.8 |
XX |
|
Saudi Arabia |
XX |
9.1 |
XX |
|
United Arab Emirates |
XX |
7.2 |
XX |
|
South Africa |
XX |
4.2 |
XX |
|
Egypt |
XX |
2.2 |
XX |
|
Israel |
XX |
3 |
XX |
|
Rest of MEA |
XX |
9.1 |
XX |
|
Latin America |
XX |
21.8 |
XX |
|
Brazil |
XX |
7.1 |
XX |
|
Mexico |
XX |
5.1 |
XX |
|
Argentina |
XX |
2.3 |
XX |
|
Chile |
XX |
1.8 |
XX |
|
Colombia |
XX |
1.1 |
XX |
|
Peru |
XX |
0.9 |
XX |
|
Rest of LA |
XX |
3.2 |
XX |
North America AI in Radiology market held the largest share of 52% of the global market in 2025 and was valued at approximately USD 390.9 million. The regional market is primarily driven by the widespread adoption of AI-enabled imaging solutions, strong healthcare IT infrastructure, growing radiologist shortages, and increasing investments in advanced diagnostic technologies across hospitals and imaging centers.
The U.S. accounted for the dominant share within North America and represented approximately 92.6% of the regional market in 2025. The market is driven by the strong presence of leading AI healthcare companies, growing FDA approvals for radiology AI software, high diagnostic imaging volumes, and increasing integration of artificial intelligence into clinical workflows.
Canada represented approximately 7.4% of the North American market in 2025 and was valued at around USD 28.9 million. The market is supported by expanding digital health initiatives, growing demand for diagnostic services in remote communities, increasing adoption of AI-assisted imaging technologies, and government investments in healthcare modernization programs.
Europe accounted for approximately 23.1% of the global AI in Radiology market in 2025 and was valued at nearly USD 173.6 million. The regional market is driven by rising healthcare digitalization, increasing implementation of AI-assisted diagnostic tools, growing demand for imaging efficiency, and supportive government initiatives promoting healthcare innovation.
The UK represented approximately 12.8% of the European market in 2025 and was valued at nearly USD 22.2 million. The market is driven by NHS-led digital transformation initiatives, increasing deployment of AI in diagnostic imaging, growing focus on reducing diagnostic backlogs, and rising adoption of workflow automation technologies.
Germany accounted for approximately 20.5% of the European market in 2025 and was valued at around USD 35.6 million. The market is supported by advanced healthcare infrastructure, strong adoption of imaging technologies, increasing investments in smart hospitals, and growing utilization of AI-powered radiology workflow solutions.
The France represented approximately 15.6% of the European market in 2025 and was valued at nearly USD 27 million. The market benefits from government-supported healthcare modernization, expanding use of AI in medical imaging, increasing demand for diagnostic accuracy, and growing investments in healthcare data infrastructure.
Italy accounted for approximately 8.6% of the European market in 2025 and was valued at around USD 14.9 million. The market is driven by rising demand for radiology efficiency, increasing adoption of digital healthcare technologies, expanding imaging service utilization, and growing implementation of AI-assisted diagnostic platforms.
The Spain represented approximately 8.2 % of the European market in 2025 and was valued at nearly USD 14.2 million. The market is supported by healthcare digitalization programs, increasing demand for imaging services, growing adoption of AI-enabled workflow solutions, and rising investments in advanced diagnostic infrastructure.
Switzerland accounted for approximately 3.1 % of the European market in 2025 and was valued at around USD 5.3 million. The market benefits from high healthcare expenditure, strong medical research capabilities, increasing adoption of precision medicine approaches, and growing integration of AI technologies into clinical imaging workflows.
The Netherlands represented approximately 2.1 % of the European market in 2025 and was valued at nearly USD 3.6 million. The market is driven by advanced digital healthcare infrastructure, strong data-sharing ecosystems, increasing focus on value-based healthcare delivery, and rising implementation of AI-powered diagnostic solutions.
Asia-Pacific accounted for approximately 18.3% of the global market in 2025 and was valued at nearly USD 137.5 million. The regional market is primarily driven by rapidly expanding healthcare infrastructure, increasing imaging procedure volumes, growing adoption of artificial intelligence technologies, and rising government investments in digital healthcare transformation.
China represented approximately 41.9 % of the Asia-Pacific market in 2025 and was valued at around USD 57.6 million. The market is supported by national AI development initiatives, rapid expansion of healthcare infrastructure, growing deployment of AI in tertiary hospitals, and increasing investments by domestic healthcare technology companies.
India accounted for approximately 7.6 % of the Asia-Pacific market in 2025 and was valued at nearly USD 10.4 million. The market is driven by rising demand for diagnostic imaging services, growing radiologist shortages, expanding digital health initiatives, and increasing adoption of cloud-based AI diagnostic platforms.
Japan represented approximately 15.8 % of the Asia-Pacific market in 2025 and was valued at around USD 21.7 million. The market benefits from a rapidly aging population, strong adoption of advanced imaging technologies, growing demand for healthcare automation, and increasing investments in AI-enabled diagnostic solutions.
South Korea represented approximately 14.3 % of the Asia-Pacific market in 2025 and was valued at around USD 19.6 million. The market is supported by a robust healthcare technology ecosystem, increasing adoption of AI in medical imaging, strong government support for digital healthcare, and growing radiology innovation activities.
Singapore accounted for approximately 3.6 % of the Asia-Pacific market in 2025 and was valued at nearly USD 4.9 million. The market is driven by advanced healthcare infrastructure, national smart healthcare initiatives, increasing investments in biomedical innovation, and growing implementation of AI-powered diagnostic technologies.
Australia represented approximately 5.2 % of the Asia-Pacific market in 2025 and was valued at around USD 7.1 million. The market benefits from healthcare digitalization efforts, increasing imaging service demand, growing adoption of AI-assisted radiology solutions, and rising investments in remote healthcare delivery systems.
Thailand represented approximately 1.3 % of the Asia-Pacific market in 2025 and was valued at around USD 1.7 million. The market is supported by expanding private healthcare investments, growing medical tourism activities, increasing adoption of advanced imaging technologies, and rising healthcare digital transformation initiatives.
Malaysia accounted for approximately 2.5 % of the Asia-Pacific market in 2025 and was valued at nearly USD 3.4 million. The market is driven by increasing healthcare modernization programs, growing prevalence of chronic diseases, expanding smart hospital projects, and rising adoption of AI-enabled diagnostic imaging solutions.
Philippines represented approximately 2 % of the Asia-Pacific market in 2025 and was valued at around USD 2.7 million. The market benefits from healthcare infrastructure expansion, growing adoption of digital health technologies, increasing demand for diagnostic services, and rising investments in healthcare modernization.
Indonesia represented approximately 1.6 % of the Asia-Pacific market in 2025 and was valued at around USD 2.2 million. The market is supported by expanding healthcare coverage, increasing healthcare infrastructure investments, growing demand for diagnostic imaging services, and rising adoption of digital healthcare solutions.
Restraints
Opportunities
Middle East & Africa AI in Radiology Market Analysis
Middle East & Africa accounted for approximately 3.7% of the global market in 2025 and was valued at nearly USD 27.8 million. The regional market is driven by healthcare infrastructure modernization, increasing investments in digital health technologies, growing demand for advanced diagnostic services, and rising adoption of AI-powered healthcare solutions.
Market Intelligence Overview (Historical, Current, Forecast):
Saudi Arabia accounted for approximately 32.8 % of the Middle East market in 2025 and was valued at nearly USD 9.1 million. The market is supported by Vision 2030 healthcare initiatives, expanding smart hospital developments, growing healthcare technology investments, and increasing deployment of AI-enabled diagnostic platforms.
United Arab Emirates represented approximately 25.9 % of the Middle East market in 2025 and was valued at around USD 7.2 million. The market benefits from strong government support for artificial intelligence, expanding healthcare innovation programs, growing medical tourism activities, and increasing adoption of advanced imaging technologies.
South Africa represented approximately 15.1 % of the Middle East market in 2025 and was valued at around USD 4.2 million. The market is driven by rising demand for diagnostic imaging services, increasing healthcare technology investments, growing tele-radiology adoption, and expanding efforts to improve healthcare accessibility.
Egypt accounted for approximately 8.2 % of the Middle East & Africa market in 2025 and was valued at nearly USD 2.2 million. The market is supported by healthcare infrastructure development, increasing digital transformation initiatives, growing demand for diagnostic efficiency, and expanding adoption of AI-assisted imaging solutions.
Israel represented approximately 7.2 % of the Middle East and Africa market in 2025 and was valued at around USD 2 million. The market benefits from a strong healthcare innovation ecosystem, advanced medical research capabilities, increasing commercialization of AI technologies, and growing adoption of precision diagnostic solutions.
Latin America accounted for approximately 2.9% of the global market in 2025 and was valued at around USD 21.8 million. The regional market is primarily driven by healthcare modernization initiatives, growing adoption of digital health technologies, increasing diagnostic imaging demand, and rising investments in healthcare infrastructure development.
2025 Latin America AI in Radiology Market Size: USD 21.8 Million
2035 Latin America AI in Radiology Market Size: USD 221.6 million
Growing modernization of diagnostic imaging infrastructure across healthcare systems
Rising incidence of cancer and cardiovascular diseases requiring advanced imaging
Increasing adoption of digital health technologies in public healthcare programs
Expansion of private healthcare investments supporting AI integration
Economic instability affecting healthcare technology investments
Uneven distribution of advanced imaging facilities across countries
Limited availability of high-quality clinical imaging datasets
Regulatory fragmentation across regional healthcare markets
Development of regional AI radiology centers of excellence
Expansion of affordable cloud-based diagnostic imaging solutions
Brazil accounted for approximately 32.9 % of the Latin America market in 2025 and was valued at nearly USD 7.1 million. The market is supported by a large patient population, increasing healthcare technology investments, expanding diagnostic imaging capacity, and growing adoption of AI-powered radiology solutions.
Large patient population generating significant imaging volumes
Growing investment in healthcare technology innovation ecosystems
Increasing adoption of AI within private hospital networks
Expansion of diagnostic imaging capacity in metropolitan regions
Complex healthcare procurement processes
Disparities in healthcare infrastructure between urban and rural areas
High dependence on imported medical AI technologies
Limited interoperability among healthcare information systems
AI-assisted imaging solutions for public healthcare efficiency improvement
Development of locally trained AI models using diverse population datasets
Mexico accounted for approximately 23.5 % of the Latin America market in 2025 and was valued at nearly USD 5.1 million. The market is driven by healthcare digitalization efforts, growing private healthcare investments, increasing demand for advanced diagnostic services, and rising adoption of AI-enabled imaging technologies.
Rising demand for diagnostic services driven by chronic disease prevalence
Increasing healthcare digitization initiatives across major health institutions
Growing private sector investment in advanced radiology technologies
Expansion of imaging services supporting medical tourism activities
Budget constraints affecting technology adoption in public hospitals
Limited access to advanced imaging technologies in rural regions
Shortage of specialized AI implementation expertise
Variability in healthcare technology standards across institutions
AI-enabled diagnostic services for expanding private healthcare chains
Growth of cross-border healthcare technology partnerships
Argentina represented approximately 10.6 % of the Latin America market in 2025 and was valued at around USD 2.3 million. The market benefits from strong clinical research activities, increasing awareness of AI-assisted diagnostics, growing healthcare modernization initiatives, and rising demand for workflow optimization solutions.
Strong academic and clinical research capabilities supporting AI innovation
Increasing demand for imaging workflow optimization solutions
Growing awareness of AI-assisted diagnostic tools among healthcare providers
Expansion of digital transformation initiatives within healthcare systems
Economic volatility impacting long-term healthcare investments
Limited capital availability for technology modernization projects
Brain drain affecting healthcare technology expertise
Aging healthcare infrastructure in certain institutions
Development of research-driven radiology AI applications
Expansion of AI-assisted imaging solutions through university collaborations
Chile represented approximately 8.6 % of the Latin America market in 2025 and was valued at around USD 1.8 million. The market is supported by government-led healthcare digital transformation programs, advanced healthcare connectivity, increasing use of diagnostic imaging technologies, and growing focus on healthcare efficiency.
Colombia accounted for approximately 5.2 % of the Latin America market in 2025 and was valued at nearly USD 1.1 million. The market is driven by expanding healthcare coverage, increasing healthcare IT investments, growing telemedicine adoption, and rising demand for accessible and efficient diagnostic imaging services.
Expanding healthcare coverage increasing demand for diagnostic imaging
Rising investments in healthcare information technology infrastructure
Growing adoption of telemedicine and remote diagnostic services
Increasing utilization of AI to support healthcare accessibility goals
Regional disparities in imaging infrastructure availability
Limited funding for advanced AI deployments in smaller facilities
Data standardization challenges across healthcare networks
Workforce shortages in specialized radiology disciplines
Opportunities
AI-supported imaging services in underserved regions
Growth of integrated tele-radiology and AI diagnostic platforms
Peru represented approximately 4.3 % of the Latin America market in 2025 and was valued at around USD 0.9 million. The market benefits from healthcare infrastructure expansion, increasing digital health adoption, growing utilization of diagnostic imaging services, and rising investments in modern healthcare technologies.
Increasing healthcare infrastructure development projects
Growing burden of chronic diseases requiring diagnostic imaging services
Rising adoption of digital healthcare initiatives
Expansion of imaging capacity in major urban healthcare facilities
Limited access to advanced diagnostic technologies outside major cities
Insufficient AI expertise within healthcare organizations
Healthcare budget limitations for emerging technologies
Fragmented healthcare delivery systems
AI-assisted radiology services for geographically isolated communities
Deployment of scalable cloud-based imaging platforms across healthcare networks
|
Company |
Market Share (%) |
|
Siemens Healthineers AG |
18.5% |
|
GE HealthCare |
16.2% |
|
Koninklijke Philips N.V. |
13.8% |
|
Canon Medical Systems |
8.9% |
|
Fujifilm Holdings Corporation |
7.6% |
Our research framework strategically segments the AI in Radiology market by Component, Technology, Modality, Application, End Use and key regional markets
By Component
By Technology
By Modality
By Application
By End Use
By Region & Country
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
|
Key Report Attributes |
Details |
|
Years Considered |
2022 to 2035 |
|
Market Size 2025 |
USD 751.8 Million |
|
Market Size 2035 |
USD 7826.5 Million |
|
Historical CAGR % (Growth rate) |
XX% from 2022 to 2025 |
|
Futuristic CAGR % (Growth rate) |
26.4% from 2026 to 2035 |
|
Segments Covered |
· By Component · By Technology · By Modality · By Application · By End-Use |
|
Regions Covered |
· North America · Europe · Asia Pacific · Latin America · Middle East & Africa |
|
Countries Covered |
USA; Canada; Germany; United Kingdom; France; Italy; Spain; Switzerland; Netherlands; China; India; Japan; South Korea; Singapore; Australia; Thailand; Malaysia; Philippines; Indonesia; Saudi Arabia; United Arab Emirates; South Africa; Egypt; Israel; Brazil; Mexico; Argentina; Chile; Colombia; Peru |
|
Competitive Landscape Overview |
· Siemens Healthineers AG · GE HealthCare · Koninklijke Philips N.V. · Canon Medical Systems · Fujifilm Holdings Corporation · Aidoc · Tempus AI · Lunit · Viz.ai · Riverain Technologies · Qure.ai · Infervision |
|
Flexible Report Customization |
The study can be customized based on geography, segment analysis, company profiling, competitive benchmarking, and strategic insights. |
|
Data Sources |
Primary and secondary sources used (Company filings, trade associations, Journals, Annual report, Publications, Surveys, Investor Presentations, and much more. |
By Component
By Technology
By Modality
By Application
By End Use
+44 1313818849
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USINDIA OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
408B, City Center, Hadapsar, Pune, India 411028
FOLLOW US
© Copyright 2026-27 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®